Inventiva S.A. SEC filings IVA
Inventiva S.A. has 228 filings in SEC EDGAR's recent list, going back to Apr 10, 2020. Its latest annual report, Form 20-F, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 2, 2026 | — |
| FWP | Free writing prospectus | Jun 2, 2026 | — |
| F-3ASR | Filing | Jun 2, 2026 | — |
| 424B5 | Prospectus supplement | Nov 13, 2025 | — |
| FWP | Free writing prospectus | Nov 13, 2025 | — |
| FWP | Free writing prospectus | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Sep 28, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 2, 2021 | — |
| 424B4 | Prospectus | Jul 13, 2020 | — |
| FWP | Free writing prospectus | Jul 10, 2020 | — |
| F-1/A | Filing | Jul 8, 2020 | — |
| F-1/A | Filing | Jul 6, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jun 19, 2020 | — |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IVA (Nasdaq), IVEVF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Daix, France
- SEC filer status
- Accelerated filer
- SEC CIK
- 1756594
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.